Elevance Health, Inc. ELV
424.74 USD -0.88 (-0.21%)
Nov 9, 2026, 10:11 AM EST
422.51 Day range 428.22
274.84 52-week range 450.69
- YTD
- +21.16%
- 1 year
- +33.66%
News
247wallst.com CVS Tumbles 12% on Plan to Split Into Two Companies Despite Earnings Beat; Elevance Health Rises 4%, Cigna Climbs 3% Wall Street is punishing CVS Health (NYSE:CVS | CVS Price Prediction) for a plan to break up the pharmacy, benefits and insurance empire it spent years building, even after a strong quarter. CVS…
benzinga.com Wells Fargo Maintains Overweight on Elevance Health, Raises Price Target to $492 Wells Fargo analyst Stephen Baxter maintains Elevance Health (NYSE:ELV) with a Overweight and raises the price target from $473 to $492.
benzinga.com 10 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com TD Cowen Maintains Buy on Elevance Health, Raises Price Target to $495 TD Cowen analyst Ryan Langston maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $465 to $495.
benzinga.com UBS Maintains Buy on Elevance Health, Raises Price Target to $523 UBS analyst A.J. Rice maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $460 to $523.
benzinga.com Guggenheim Maintains Buy on Elevance Health, Raises Price Target to $485 Guggenheim analyst Jason Cassorla maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $460 to $485.
benzinga.com Morgan Stanley Maintains Equal-Weight on Elevance Health, Raises Price Target to $449 Morgan Stanley analyst Erin Wright maintains Elevance Health (NYSE:ELV) with a Equal-Weight and raises the price target from $404 to $449.- benzinga.com RBC Capital Maintains Sector Perform on Elevance Health, Raises Price Target to $455 RBC Capital analyst Ben Hendrix maintains Elevance Health (NYSE:ELV) with a Sector Perform and raises the price target from $424 to $455.
- benzinga.com Barclays Maintains Overweight on Elevance Health, Raises Price Target to $472 Barclays analyst Andrew Mok maintains Elevance Health (NYSE:ELV) with a Overweight and raises the price target from $469 to $472.
benzinga.com Baird Maintains Neutral on Elevance Health, Raises Price Target to $406 Baird analyst Michael Ha maintains Elevance Health (NYSE:ELV) with a Neutral and raises the price target from $393 to $406.
benzinga.com Meta, Tesla On Deck Wednesday As AI Spending, Auto Demand Face Test Meta Platforms and Tesla headline Wednesday’s reports, with investors focused on whether AI investment can keep driving growth while Tesla’s core auto business weakens. Philip Morris International,…
benzinga.com Elevance Health Q3 2026 Earnings Call Transcript Elevance Health (NYSE:ELV) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to…
benzinga.com Elevance Health Q3 Adj. EPS $6.99 Beats $4.68 Estimate, Sales $50.440B Beat $49.213B Estimate Elevance Health (NYSE:ELV) reported quarterly earnings of $6.99 per share which beat the analyst consensus estimate of $4.68 by 49.36 percent. This is a 15.92 percent increase over earnings of $6.03…- benzinga.com Guggenheim Maintains Buy on Elevance Health, Raises Price Target to $460 Guggenheim analyst Jason Cassorla maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $455 to $460.
- benzinga.com Humana Reaffirms FY26 Adjusted EPS Guidance Of At Least $9; Exceeding Goal Of Top Quartile Results In 2027 Medicare Advantage Star Ratings; Expects 2028 Benefit For One-Time Investments And Return To Shareholders Humana affirms its guidance of at least $9.00 in adjusted earnings per common share ("Adjusted EPS"), for the year ending December 31, 2026 ("FY 2026"). This guidance is consistent with the guidance
benzinga.com Barclays Maintains Overweight on Elevance Health, Raises Price Target to $469 Barclays analyst Andrew Mok maintains Elevance Health (NYSE:ELV) with a Overweight and raises the price target from $457 to $469.
benzinga.com Stock Market Today: Nasdaq 100 Tumbles as Oil Spikes 6%, Yields Hit 19-Year High Crude jumped 6% and 30-year Treasury yields hit levels last seen in 2007 as a hot PPI print pushed Fed rate-hike odds toward 70% ahead of Friday's CPI.
benzinga.com Elevance Health Stock is Moving Higher After FY26 EPS Reaffirmation Elevance Health shares are jumping Thursday after the company reaffirmed its FY26 earnings guidance ahead of a series of investor meetings.
benzinga.com Oil Surges, Treasury Yields Climb a Fifth Day, Software Retreats: Stock Market Today The 10-year Treasury yield hit a 19-month high and crude jumped above $88 as traders lifted Fed rate-hike odds to 68%, cracking high-multiple software stocks.
benzinga.com 10 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com Warren Buffett Disciple Seth Klarman Bets on Cruise Lines, Auto Parts, Amazon and Bill Ackman in Q2 Value investor Seth Klarman reveals his latest stock picks in a second quarter filing for hedge fund Baupost Group.
benzinga.com Mark Cuban Wants Investors Out of Health Insurers. That’s Tough If You Own These ETFs Mark Cuban is urging funds to divest from major health insurers. Here’s how broad-market ETFs remain exposed to the companies he’s targeting.
benzinga.com 10 Health Care Stocks With Whale Alerts In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com Mark Cuban Urges Investors to Pressure Health Insurers Over Healthcare Costs: ‘You Can Make a Difference’ Mark Cuban urged investors to pressure health insurers over healthcare costs, calling for funds to divest their stakes.- benzinga.com Leerink Partners Maintains Market Perform on Elevance Health, Raises Price Target to $395 Leerink Partners analyst Whit Mayo maintains Elevance Health (NYSE:ELV) with a Market Perform and raises the price target from $364 to $395.
benzinga.com UnitedHealth Rally Sparks Bullish Case for Healthcare ETFs Despite Medicare Advantage Losses UnitedHealth's (UNH) strong earnings and raised outlook lifted healthcare ETFs despite a sharp decline in Medicare Advantage membership.
benzinga.com RBC Capital Maintains Sector Perform on Elevance Health, Lowers Price Target to $424 RBC Capital analyst Ben Hendrix maintains Elevance Health (NYSE:ELV) with a Sector Perform and lowers the price target from $439 to $424.- benzinga.com Wells Fargo Maintains Overweight on Elevance Health, Lowers Price Target to $473 Wells Fargo analyst Stephen Baxter maintains Elevance Health (NYSE:ELV) with a Overweight and lowers the price target from $492 to $473.
benzinga.com Medicaid's New Twice-A-Year Eligibility Check Starts In December: How To Keep Your Coverage And Which Stocks Feel It Starting in December 2026, millions of Medicaid enrollees will have to prove they still qualify twice as often as they do today, and the Urban Institute estimates the change could push 2 to 3.1…
benzinga.com These Analysts Revise Their Forecasts On Elevance Health Following Q2 Earnings Elevance Health Inc. (NYSE:ELV) reported strong Q2 results and raised full-year guidance. Analysts have adjusted price targets for ELV stock.
benzinga.com Guggenheim Maintains Buy on Elevance Health, Raises Price Target to $455 Guggenheim analyst Jason Cassorla maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $399 to $455.- benzinga.com Barclays Maintains Overweight on Elevance Health, Lowers Price Target to $457 Barclays analyst Andrew Mok maintains Elevance Health (NYSE:ELV) with a Overweight and lowers the price target from $480 to $457.
- benzinga.com Baird Maintains Neutral on Elevance Health, Raises Price Target to $393 Baird analyst Michael Ha maintains Elevance Health (NYSE:ELV) with a Neutral and raises the price target from $331 to $393.
benzinga.com Elevance Health's Small Outlook Boost Disappoints, Stock Sinks Elevance Health (ELV) beats Q2 expectations but triggers a broader managed-care selloff after a conservative guidance raise.
benzinga.com Phoenix Education Partners, Pentair And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session US stock futures mostly higher, Nasdaq up by 100 points. Phoenix Education falls after cutting sales guidance. Other stocks also down in pre-market.
benzinga.com Earnings Scheduled For July 15, 2026 Companies Reporting Before The Bell • VCI Global (NASDAQ:VCIG) is estimated to report earnings for its Fiscal Year 2025. • PNC Financial Services Gr (NYSE:PNC) is projected to report quarterly…
benzinga.com Insurer Elevance Seeks Recalculated Medicare Star Rating in Lawsuit Elevance sued HHS and CMS, alleging unequal Medicare Star Ratings treatment cost it about $115 million in 2027 bonus payments.
benzinga.com This CH Robinson Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday Top Wall Street analysts upgraded SM Energy, Rubrik Inc, CH Robinson Worldwide Inc, Elevance Health Inc, and Centene Corp. Analysts also have a positive outlook on CHRW stock.- benzinga.com 10 Health Care Stocks Whale Activity In Today's Session
benzinga.com Apple, Amazon, TSMC Top List Of Earnings Triple Plays As Beat-And-Raise Stocks Surge Apple, Amazon and TSMC are among the largest companies to deliver earnings "triple plays" this season.- benzinga.com Earnings Scheduled For April 22, 2026
- benzinga.com CMS Issues Guidance On New Limits For Federal Medicaid & CHIP Funding Restrictions For Noncitizens; States Will Need To Implement Statutory Changes By October 1 2026 https://www.medicaid.gov/federal-policy-guidance/downloads/sho26001.pdf
benzinga.com This Inhibrx Biosciences Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday Top Wall Street analysts changed outlook on top names. See complete rating changes, including upgrades and downgrades, on Benzinga's analyst ratings page.- benzinga.com 9 Health Care Stocks With Whale Alerts In Today's Session
benzinga.com UnitedHealth, Humana, CVS Jump As CMS Boosts Medicare Payments Medicare Advantage stocks surge as CMS finalizes 2027 rates. Read about the 2.48% base rate hike and the impact on CVS, UNH, and ALHC.- benzinga.com Medicare Finalizes 2.48% Rate Hike For Private Insurers In 2027 https://www.cms.gov/newsroom/press-releases/cms-finalizes-2027-medicare-advantage-part-d-payment-policies-strengthen-accountability-long-term
- benzinga.com Myomo Signs Agreement With Elevance Health Over Commercial, Medicare Advantage, Medicaid Plans; Expand Myomo's MyoPro Powered Arm And Hand Orthoses Myomo, Inc. (NYSE:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis,…
benzinga.com Palantir, Energy Stocks Rally, Cruise Lines Tumble On US And Israeli-Iran War: What's Moving Markets Monday? Wall Street traded firmly higher at midday in New York on Monday, reversing overnight futures losses as investors brushed aside escalating tensions in the Middle East.
benzinga.com Warren Buffett Disciple Seth Klarman Differs With Mentor On This Magnificent Seven Stock: One Is Buying, One Is Selling An investing disciple of Warren Buffett shares his Q4 portfolio changes, which includes a difference of opinion on one Magnificent Seven stock.
benzinga.com Gold Rallies To $5,300, Memory Stocks Go Wild: What's Moving Markets Wednesday? Wall Street posted modest gains on Wednesday, while gold extended its relentless rally, shattering records above $5,300 an ounce ahead of the Federal Open Market Committee meeting.